CommentMicrowave or radiofrequency ablation: clinically equivalent?
References (8)
- et al.
Role of local ablative therapy for hepatocellular carcinoma
J Clin Exp Hepatol
(2014) - et al.
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Lancet Oncol
(2015) - et al.
Hepatocellular carcinoma
Lancet
(2018) - et al.
Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis
Ann Surg Oncol
(2003)
There are more references available in the full text version of this article.
Cited by (5)
Adverse Events Related to Partial Splenic Embolization for the Treatment of Hypersplenism: A Systematic Review
2020, Journal of Vascular and Interventional RadiologyCitation Excerpt :Nonetheless, the authors were able to regrade the complications presented in published papers according to newly proposed PSE-specific criteria for major complications, which gives a comprehensive view of the adverse events of this procedure. Newer modalities have been introduced as alternatives to PSE to further reduce the risk of complication and control the volume of destruction to the spleen, namely, radiofrequency ablation, microwave ablation, radioembolization, and high-intensity focused ultrasound (HIFU) therapy (26,31,56–58). These new procedures purportedly carry benefit, are less invasive, and cause fewer complications than PSE.
Combined minimally invasive treatment of liver and bile ducts malignancies
2020, Annals of HPB Surgery
© 2018 Elsevier Ltd. All rights reserved.